Association between Dietary Magnesium Intake and Glycemic Markers in Ghanaian Women of Reproductive Age: A Pilot Cross-Sectional Study by Bentil, Helena J. et al.
University of Rhode Island 
DigitalCommons@URI 
Nutrition and Food Sciences Faculty 
Publications Nutrition and Food Sciences 
2021 
Association between Dietary Magnesium Intake and Glycemic 
Markers in Ghanaian Women of Reproductive Age: A Pilot Cross-
Sectional Study 
Helena J. Bentil 
Alyssa M. Abreu 
Seth Adu-Afarwuah 
Joseph S. Rossi 
Alison Tovar 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.uri.edu/nfs_facpubs 
Authors 
Helena J. Bentil, Alyssa M. Abreu, Seth Adu-Afarwuah, Joseph S. Rossi, Alison Tovar, and Brietta M. Oaks 
nutrients
Article
Association between Dietary Magnesium Intake and Glycemic
Markers in Ghanaian Women of Reproductive Age: A Pilot
Cross-Sectional Study
Helena J. Bentil 1,* , Alyssa M. Abreu 1 , Seth Adu-Afarwuah 2, Joseph S. Rossi 3, Alison Tovar 1
and Brietta M. Oaks 1


Citation: Bentil, H.J.; Abreu, A.M.;
Adu-Afarwuah, S.; Rossi, J.S.; Tovar,
A.; Oaks, B.M. Association between
Dietary Magnesium Intake and
Glycemic Markers in Ghanaian
Women of Reproductive Age: A Pilot
Cross-Sectional Study. Nutrients 2021,
13, 4141. https://doi.org/10.3390/
nu13114141
Academic Editors: Bahram H.
Arjmandi and Roberto Iacone
Received: 24 September 2021
Accepted: 16 November 2021
Published: 19 November 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Department of Nutrition and Food Sciences, University of Rhode Island, Kingston, RI 02881, USA;
amabreu@uri.edu (A.M.A.); alison_tovar@uri.edu (A.T.); boaks@uri.edu (B.M.O.)
2 Department of Nutrition and Food Science, University of Ghana, Accra LG 25, Ghana;
sadu-afarwuah@ug.edu.gh
3 Department of Psychology, University of Rhode Island, Kingston, RI 02881, USA; jsrossi@uri.edu
* Correspondence: helena_bentil@uri.edu
Abstract: Low magnesium intake has been shown to be associated with an increased risk of type
2 diabetes mellitus (T2DM) in several studies conducted in high-income countries. However, very
few studies have been performed in Africa, where many countries have a growing rate of T2DM.
We conducted a pilot cross-sectional study among 63 women in Ghana to investigate the association
between magnesium intake and glycemic markers. We assessed dietary magnesium using a food
frequency questionnaire and glycemic markers using fasting blood glucose and glycated hemoglobin
A1c (HbA1c). Our findings showed that the mean magnesium intake was 200 ± 116 mg/day. The
prevalence of T2DM was 5% by measuring fasting blood glucose and 8% by measuring HbA1c.
Unadjusted linear regression models revealed that higher magnesium intake significantly predicted
higher fasting blood glucose levels (β = 0.31; 95% CI: 0.07, 0.55; p = 0.01) and HbA1c levels (β = 0.26;
95% CI: 0.01, 0.51; p = 0.04). In adjusted analyses, magnesium intake was no longer significantly
associated with either fasting blood glucose levels (β = 0.22; 95% CI: −0.03, 0.46; p = 0.08) or HbA1c
levels (β = 0.15; 95% CI: −0.08, 0.39; p = 0.20). In conclusion, our study did not show a significant
association between magnesium intake and glycemic markers in women of reproductive age in
Ghana. The results of this study need to be further substantiated because this was the first study to
examine magnesium intake and glycemic markers in this population in Africa.
Keywords: magnesium; diabetes; nutrition transition; women of reproductive age; Ghana
1. Introduction
Magnesium is a critical mineral in the body serving as a cofactor for more than
300 enzymes that regulate diverse biochemical reactions, including blood glucose [1].
Magnesium deficiency can affect insulin regulation and may increase the risk of diabetes
due to its essential role in the activation of the tyrosine kinase enzyme for insulin receptor
activity [2]. Thus, magnesium deficiency could impair the insulin signal transduction
pathway by interfering with the tyrosine kinase activity of the insulin receptor [1,2].
Several studies have reported that low magnesium intake is associated with type 2
diabetes mellitus (T2DM) [3–6], and randomized controlled trials show that magnesium
supplementation improves glucose parameters in adults with diabetes and improves
insulin sensitivity in those at high risk of diabetes [7–10]. However, the majority of research
has been conducted in high-income countries [3–10], and no study has examined the
relationship between magnesium intake and T2DM in Africa.
Ghana, like many countries in Africa, is experiencing a nutrition transition, with
less intake of traditional foods and increased consumption of processed foods typically
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associated with a western diet [11]. As magnesium is present in many traditional Ghanaian
foods [12] and typically absent in processed foods [13], magnesium intake has likely been
decreasing in Ghana. Simultaneously, the rate of T2DM has been increasing and it is now
estimated that among women (aged 18 years and over) in Ghana, T2DM has increased
from 5.0% in 2000 to 6.6% in 2014 [14]. The increase in T2DM is particularly concerning
for women of reproductive age, as diabetes during pregnancy can lead to adverse birth
outcomes such as restricted fetal growth, intrauterine growth restriction, and preterm
labor, as well as an increased risk of future diabetes [15–17]. Furthermore, low magnesium
consumption during pregnancy plays a role in the fetal programming of adult disease [15].
Intrauterine magnesium deficiency in the fetus was linked to insulin resistance after birth,
increasing the risk of metabolic syndrome in adulthood [15]. It is unknown whether
magnesium deficiency is a factor contributing to the prevalence of T2DM in Ghana as the
average magnesium intake in the current diet is unknown. Therefore, this study intends to
fill a critical void in our understanding of diet and T2DM risk in Ghana.
To address this knowledge gap, we conducted a pilot study to investigate the as-
sociation between dietary magnesium intake and two glycemic markers of T2DM risk:
fasting blood glucose and glycated hemoglobin A1c (HbA1c). We hypothesized that lower
dietary magnesium intake would be associated with higher fasting blood glucose and
higher HbA1c.
2. Materials and Methods
2.1. Study Design, Setting, and Participants
We conducted a pilot cross-sectional study between July and August 2019 among
women of reproductive age living in Odumase Krobo, a peri-urban area and the district
capital of Lower Manya Krobo District in the Eastern Region of Ghana, about 70 km north
of the national capital, Accra. The study was approved by the Ghana Health Service Ethical
IRB (REF# GHS-ERC016/10/18) and the University of Rhode Island IRB (REF# BI1819-005).
We obtained written informed consent from all study participants.
To be eligible for enrollment, women had to: (a) be between 18 and 49 years old;
(b) reside in Odumase Krobo; (c) be able to speak Krobo, Twi, or English; (d) and be
non-pregnant by self-report. Pregnant women were excluded because their blood glucose
fluctuates during pregnancy. We decided on a sample size of 60 based on a recommendation
by Sim et al. [18] for pilot studies.
A list of census enumeration areas for Odumase Krobo was obtained from the Ghana
Statistical Services. The list had a total of 19 enumeration areas (EAs) in ascending order
according to the EAs ID code/number. Out of the total 19 EAs, 5 EAs were randomly
selected. To select the 5 EAs, we first calculated the interval rate by dividing the total
number of EAs (19) by the number of EAs to be selected (5), which is approximately 4.
Thus, for the 5 EAs, we selected every fourth EA from the list of total EAs. These included
the fourth, eighth, twelfth, sixteenth, and eighteenth enumeration areas. We selected a
total of 12 households per EA. Every second household that had women within the ages of
18–49 years was selected from the list of households in each EA.
The selected households were visited, and women in each household were further
screened for eligibility. Women who were interested and eligible to participate gave their
informed consent by either signature or thumbprint. If the eligible woman in the selected
household was not interested, the next household was selected from the list of households
until a sample size of 60 was obtained. In situations where there was more than one
eligible woman in a household, only one was selected using the simple random sampling
procedure (balloting technique). Ballot papers equivalent to the number of eligible women
in the household were all labeled “No” except for one, which was labeled “Yes”, and were
folded and presented to the women for them to choose. The eligible woman who picked
the paper labeled “Yes” was enrolled in the study.
All enrolled women received two home visits within two days. During the first
home visit, which took approximately two hours, women consented and completed an
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interviewer-administered survey and a food frequency questionnaire (FFQ) to collect infor-
mation on socio-demographic characteristics and dietary magnesium intake, respectively
as well as height and weight measurements. Blood tests were performed during the
second home visit, which took about a half-hour, to collect information on hemoglobin
concentrations, fasting blood glucose, and HbA1c.
2.2. Study Data Collection
An interviewer-administered questionnaire was used to collect data on socio-demogra-
phic characteristics, including age, ethnicity, marital status, number of children, educational
level, occupation, and living conditions, including sources of drinking water, sanitation
facility, type of building material, type of flooring, and household ownership of assets
(e.g., electricity, car, refrigerator/freezer, television, video player, computer, gas/electric
stove, and air conditioner). We assessed household socioeconomic status from the reported
household’s ownership of the following 18 items: color/black TV, fixed telephone, mo-
bile phone, generator, computer/laptop, refrigerator, freezer, washing machine, sewing
machine, radio, bed, DVD/VCD, bicycle, motorcycle, table, cabinet/cupboard, camera,
and car/truck, as well as access to internet and electricity. Based on these parameters, the
wealth index was determined using principal components analysis and categorized into
quintiles (lowest, second, middle, fourth, and highest).
To estimate body mass index (BMI), we measured height and weight using stan-
dard procedures with a height board (UNICEF S0114540) and a digital weight scale
(SECA 874, Chino, CA, USA), respectively. Body mass index (BMI) was calculated as weight
(kg)/height (m)2. Study participants were classified as underweight (BMI < 18.5 kg/m2),
normal weight (BMI 18.5–24.9 kg/m2), overweight (BMI 25.0–30.0 kg/m2), or obese
(BMI ≥ 30.0 kg/m2), which was assessed according to the cut-off values by the World
Health Organization [19].
We collected information on dietary magnesium intake using a semi-quantitative
150-item food frequency questionnaire (FFQ) based on the FFQ used in larger studies
and national surveys in Ghana [20–22]. For each food item, we assigned a portion size
using standard household measures such as cups, tablespoons, teaspoons, or glasses as
well as using photographs from the Food Amounts Booklet [23]. Study participants were
asked how often, on average, they consumed the specified amount in the past 7 days. The
frequency of consumption of specified portion size was asked in six categories: never,
once per week, 2 times per week, 3–4 times per week, 5–6 times per week, once per
day, and 2 or more times per day. We calculated magnesium intake by multiplying the
frequency of consumption of each food item by the magnesium content of the specified
portion size using ESHA Food Processor Nutrition Analysis software, version 10.8 (ESHA
Research Inc, 2010, Salem, OR, USA) and the West African Food Composition table. We
also collected information on dietary supplement intake. However, none of the reported
dietary supplements contained magnesium and were therefore not included in the analysis.
We obtained blood samples from the study participants after an overnight fast fol-
lowing a finger prick with disposable lancets on the second home visit. The markers of
glycemia assessed were fasting blood glucose and glycated hemoglobin A1c (HbA1c).
We measured fasting blood glucose (FBG) and HbA1c levels once using a glucose me-
ter (AccuChek Aviva Plus) and an HbA1c meter (A1CNow+ System PTS Diagnostics,
Whitestown, IN, USA), respectively. Women at risk of diabetes were defined as having an
FBG ≥ 126 mg/dL or HbA1C ≥ 6.5%, women at risk of prediabetes were defined as having
an FBG of 100–125 mg/dL or HbA1C of 5.7–6.4%, and normal glycemia as having an FBG
less than 100 mg/dL or HbA1c less than 5.7% according to the International Diabetes
Federation American Diabetes Association criteria [24]. We also measured hemoglobin
concentrations. A drop of blood was drawn into a microcuvette and analyzed using a
HemoCue™ Hb 201 Analyzer (Radiometer Medical Aps, Brønshøj, Denmark). Study
participants were classified as normal (Hb ≥ 12.0 g/dL), mild anemia (Hb 11.0–11.9 g/dL),
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moderate anemia (Hb 8.0–10.9 g/dL), or severe anemia (Hb < 8.0 g/dL), and were assessed
according to the cut-off values by the World Health Organization [25].
2.3. Statistical Analysis
We analyzed the study data with SAS Studio 5.2 (SAS Institute, Cary, NC, USA).
Continuous variables are presented as mean ± SD, and categorical variables as frequency
(%). Multiple linear regression was used to determine the association between dietary
magnesium intake and blood glucose concentration. The dependent variables were the
glycemic markers (fasting blood glucose and HbA1c), and dietary magnesium intake was
the independent variable. We used the Shapiro–Wilk test to check the normality of residuals
and inversely transformed the outcome variable, fasting blood glucose. For the adjusted
regression analysis, bivariate analysis was first performed to determine whether socio-
demographic variables, BMI, and hemoglobin concentration, which were selected based
on prior literature [26–28], were significantly associated with both the dependent and inde-
pendent variables. Variables found to be statistically significant at p < 0.10 were included
as covariates in the adjusted regression models. Age was the only covariate found to be
significantly associated with both the dependent variables (fasting blood glucose or HbA1c)
and the independent variable (magnesium intake). BMI was also included as a covariate
because of its association with blood glucose concentrations [28]. The independent variable
and covariates in the adjusted model were checked for multicollinearity by estimating
the variance inflation factor (VIF) for all variables; no correlation was identified between
the variables (VIF < 2). Upon examining studentized residuals larger than 3 standard
deviations, we determined that there was an outlier in magnesium intake. Given that the
intake was still considered plausible (658 mg/day) [29], we decided to keep this value in
the regression model. However, we conducted a post hoc linear regression where we split
magnesium intake into 3 groups to test the relationship between magnesium intake and
the glycemic markers and thus mitigated the effect of the outlier in the magnesium intake
distribution. We also performed a post hoc analysis of logistic regression and predicted
the risk of hyperglycemia (FBG ≥ 100 mg/dL or HbA1c ≥ 5.7%) according to magnesium
intake. A p-value of< 0.05 was considered statistically significant. Statistical power analysis
was conducted for a multiple regression analysis consisting of four potential covariates
and assuming alpha = 0.05 for a planned sample size of 60 study participants. The results
suggested that power would be 0.80 for an overall model R2 of 0.18 and that a model R2 of
0.10 or greater would be detected as statistically significant at p < 0.05.
3. Results
3.1. Background Characteristics of Study Participants
Table 1 summarizes the background characteristics of the study participants. A to-
tal of 63 women were enrolled in the study. The mean ± SD age of the women was
29.5 ± 8.5 years. The majority of the women were Ga-Adangmes (98.4%), had attended
school (88.9%), were employed (61.9%), and had one or more children (77.8%). About
30% were classified as overweight, 14% were classified as obese, and only 1.6% were
classified as underweight. More than half of the women were anemic (57.1%), and 3% of
the women were severely anemic. Most of the women in our study had normal glycemia:
fasting blood glucose (55.6%) vs. HbA1c (67.2%). About 40% and 25% of the women were
classified as having prediabetes per fasting blood glucose and HbA1c levels, respectively,
while 5% (from fasting blood glucose measurements) vs. 8% (from HbA1c measurements)
were classified as having diabetes. The mean ± SD daily intake of magnesium in the
study population was 200 ± 116 mg. The majority of the women (84%) in this study did
not meet the recommended daily magnesium intake as required by their age. The daily
recommendation by age is 360 mg for 14–18 years, 310 mg for 19–30 years, and 320 mg for
31+ years.
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Table 1. Background characteristics of the study population.
Variable Frequency (%)/Mean ± SD
Age, years 29.5 ± 8.5
Marital status










KG/primary/JHS (Low) 42 (66.7%)
SHS/tertiary (High) 14 (22.2%)
Occupation






Mean BMI, kg/m2 25.2 ± 5.1





Mean fasting blood glucose, mg/dL 101.2 ± 15.2
Fasting blood glucose category
Normal (<100 mg/dL) 35 (55.6%)
Impaired fasting glucose (100–126 mg/dL), at risk 25 (39.7%)
Raised fasting blood glucose (≥126 mg/dL), at risk 3 (4.8%)
Mean HbA1c % (n = 61) 5.5 ± 0.6
HbA1c category (n = 61)
Normal (<5.7) 41 (67.2%)
Pre-diabetes (5.7–6.4), at risk 15 (24.6%)
Diabetes (≥6.5), at risk 5 (8.2%)
Mean hemoglobin concentration, g/dL 11.5 ±1.7
Anemia n (%)
Normal (≥12 g/dL) 27 (42.9%)
Mild (11.9–11 g/dL) 14 (22.2%)
Moderate (10.9–8 g/dL) 20 (31.8%)
Severe (<8 g/dL) 2 (3.2%)
Mean Magnesium Intake, mg/day 200 ± 116
RDA for Magnesium intake
Met RDA 10 (15.9%)
Did not meet RDA 53 (84.1%)
3.2. Association between Magnesium Intake and Glycemic Markers
Table 2 shows the associations between magnesium intake and glycemic markers.
In both unadjusted models, higher magnesium intake was significantly associated with
higher fasting blood glucose levels (β = 0.31, p = 0.01) and higher HbA1c levels (β = 0.26,
p = 0.04). This means that a one SD increase in magnesium intake (1 SD = 116 mg/d) was
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associated with a higher fasting blood glucose of 0.31 mg/dL (95% CI: 0.07, 0.55) and a
higher HbA1c of 0.26% (95% CI: 0.01, 0.51). After adjusting for covariates, magnesium
intake was no longer significantly associated with fasting blood glucose (β = 0.22, 95% CI:
−0.03, 0.46, p = 0.08) and HbA1c levels (β = 0.15, 95% CI: −0.08, 0.39, p = 0.20). In our post
hoc tertile analysis, presented in Supplementary Table S1, the adjusted models also showed
no relationship between magnesium intake and fasting blood glucose (β = 0.10, 95% CI:
−0.15, 0.35, p = 0.43) and HbA1c (β = 0.18, 95% CI: −0.04, 0.32, p = 0.13). However, the
unadjusted models, showed a non-significant relationship between magnesium intake and
fasting blood glucose (β = 0.20, 95% CI: −0.05, 0.45, p = 0.12) and HbA1c levels (β = 0.26,
95% CI: −0.004, 0.39, p = 0.05).
Table 2. Association between magnesium intake and glycemic markers.




β 95% CI p-Value β 95% CI p-Value
Magnesium intake
Unadjusted 0.31 0.07, 0.55 0.01 0.26 0.01, 0.51 0.04
Adjusted 1 0.22 −0.03, 0.46 0.08 0.15 −0.08, 0.39 0.20
1 Adjusted for age and BMI.
3.3. Post Hoc Analysis Showing Risk of Hyperglycemia in Women of Reproductive Age According
to Magnesium Intake
Logistic regression was performed to predict hyperglycemia based on magnesium
intake categorized according to the RDA by age for magnesium (Table 3). Both unadjusted
and adjusted models showed no significant relationship between magnesium intake and
glycemic markers.
Table 3. Risk of hyperglycemia in women of reproductive age according to magnesium intake.
Magnesium Intake
(mg/Day)




Unadjusted Adjusted 1 Unadjusted Adjusted 1
OR 95% CI p Value OR 95% CI p-Value OR 95% CI p Value OR 95% CI p-Value
Met RDA 1.00 1.00 1.00 1.00
Unmet RDA 0.78 0.20, 3.00 0.70 0.89 0.21, 3.72 0.86 0.46 0.12, 1.81 0.26 0.42 0.07, 2.45 0.33
1 Adjusted for age and BMI.
4. Discussion
The aim of this study was to explore the association between magnesium intake and
risk of type 2 diabetes in a sample of women of reproductive age in Ghana. Our study
showed no associations between magnesium intake and glycemic markers (fasting blood
glucose and HbA1c) after adjusting for covariates. This, however, contrasts the findings of
other studies. A recent meta-analysis of 41 prospective cohort studies found a significant
inverse association between magnesium intake and risk of type 2 diabetes [5]. Similarly,
the Black Women’s Health Study, an 8-year prospective study of 41,186 U.S. Black women
found that a higher dietary magnesium intake was associated with a lower risk of type 2
diabetes [30]. This contrast could be due to differences in geographic regions as several
of these studies were conducted in Europe, Australia, North America, and Asia. There
are no previously published studies conducted in African populations; therefore, further
research, especially longitudinal studies, is warranted to confirm our results. There are
some studies, however, that have found no association between magnesium intake and risk
of type 2 diabetes [31,32]. In particular, a double-blind randomized cross-over trial [32],
which investigated the effects of magnesium supplementation on metabolic control and
insulin sensitivity in 98 type 2 diabetic patients, did not find magnesium supplementation
to have any significant improvement in the fasting glucose, HbA1c, insulin, or homeostatic
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model assessment—insulin resistance (HOMA-IR) of the patients. However, as the study
was completed in type 2 diabetic patients, the authors attributed the finding to magnesium
loss due to increased urinary magnesium excretion.
Of note, in our unadjusted results, we found positive associations between magnesium
intake and glycemic markers, suggesting that a higher magnesium intake predicts higher
fasting blood glucose and HbA1c levels in women of reproductive age in Ghana. However,
this finding is in contrast to the inverse associations reported in previous studies [3–5,7,8,30].
A possible explanation regarding the positive relationship observed between magnesium
intake and glycemic markers might be related to the number of factors that interfere with
magnesium absorption following intake. Specifically, dietary aluminum has been shown to
cause approximately a five-fold reduction in the absorption of magnesium in the gut [13,33].
Apart from the dietary sources of aluminum, the use of aluminum utensils in cooking
is considered to result in significant increases in the aluminum content of food due to
the leaching of aluminum from aluminum utensils [33,34]. In our study setting, as in
many parts of Africa [35], aluminum utensils were used in cooking, which may have
contributed to an increase in the intake of this metal in addition to the dietary sources,
including vegetables, food additives, cereals, and cereal products [34]. In addition, the
major sources of magnesium in our study were millet and maize. These foods, especially
millet, are consumed in the form of porridge, hausa koko, which is sweetened with sugar.
Thus, although millet porridge is a significant source of magnesium, it also contains sugar,
the high intake of which decreases the absorption of magnesium in the gut and causes
increased magnesium excretion via the kidneys [13,33]. We acknowledge that though
our unadjusted findings may be of note, only showing the bivariate relationship between
magnesium intake and risk of type 2 diabetes without controlling for covariates. That said,
in our study, adjustment for age and BMI attenuated the effect of our results. We observed
higher blood glucose concentrations in older and overweight women than in younger and
normal-weight women.
Our study has some limitations. First, the cross-sectional nature of this study means
that no causal associations between magnesium intake and risk of type 2 diabetes can be
established. Second, we acknowledge that the possible recall bias in the dietary assessment
and the common habit for people in Ghana to share or consume food from a shared bowl
could have led to underreporting of food intakes. Participants may have had difficulties
remembering the foods and quantities they consumed the previous week, which could have
affected the reported intake. Third, we had a small sample size and our target population
was recruited from a particular region in Ghana, which limits generalizability. However,
the diets of the people in this area are roughly similar to those of most people in Ghana.
Fourth, magnesium intake from drinking water was not assessed, which is consistent with
previous studies [5–9]. The primary source of drinking water in our study was tap water.
Tap water in Ghana is softened, which essentially reduces the concentrations of minerals
such as magnesium from the water. The mean magnesium concentrations of drinking
water vary between 1 and 20 mg/L [36]. Assuming study participants consumed 1 to 1.5 L
of water per day, this would correspond to approximately 1 to 30 mg/d of magnesium,
and we think that this would not change the null association we found in our study.
Our study has several strengths. We used the random sampling method to recruit
participants, reducing bias. We had information about several covariates, including socio-
demographic factors, hemoglobin concentrations and BMI for which we were able to
perform an adjusted analysis. Additionally, we used two glycemic markers to assess the
risk of type 2 diabetes. Fasting blood glucose measures blood glucose level at a single point
in time and HbA1c measures blood glucose levels in the previous 3 months, integrating
both fasting and postprandial hyperglycemia [37].
In summary, we observed no significant association between magnesium intake and
glycemic markers in women of reproductive age in Ghana. Given the role magnesium
plays in glucose and insulin homeostasis and the fact that, in this study population, a high
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percentage of women did not meet the RDA for magnesium, more studies with longitudinal
design are needed to confirm the reported results.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/nu13114141/s1, Table S1: Association of tertile analysis of magnesium intake and
glycemic markers.
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